Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pacing and sleep apnea

This article was originally published in The Gray Sheet

Executive Summary

Atrial overdrive pacing significantly reduced the number of episodes of sleep apnea (central or obstructive) without reducing total sleep time in 15 patients over 60 that had been implanted with pacemakers at least one year earlier for symptomatic sinus bradycardia, French researchers report in the Feb. 7 New England Journal of Medicine. The results are "tantalizing because they imply that novel non-mechanical treatment options may be found for sleep apnea and because they suggest that the heart may be important in controlling respiration," Daniel Gottlieb, MD/MPH, Boston University, comments in an accompanying editorial. "Identification of the specific neural pathways involved may advance efforts to develop much-needed pharmacologic therapies"...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016097

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel